Sarepta Therapeutics, Inc.
SRPT· Nasdaq
SRPTSarepta Therapeutics, Inc.
Filed May 4, 2022 · 10-Q · 34 days after period end · 0000950170-22-007375
| Metric | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Revenue | $188.83M | $124.93M | $100.45M | $87.01M |
| Net Income | -$105.03M | -$167.25M | -$17.49M | -$76.64M |
| EPS Diluted | -$1.20 | -$2.10 | -$0.23 | -$1.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sarepta Therapeutics, Inc. · CIK 873303 · Engraved from SEC EDGAR
ended Mar 31, 2022 · filed May 4, 2022 · 34 d after period end
